EligibleTrials

Safety and Efficacy of Workflows of High Volume Single Operators in a LAAO Device Implant Procedural Day

Recruiting · NCT06436924 · Observational (researchers observe without assigning treatment) · Lead sponsor: Heart Rhythm Clinical and Research Solutions, LLC

View the official record on ClinicalTrials.gov →
Atrial Fibrillation

Interventions studied

Left Atrial Appendage Device Implant

What this trial is about

SAFE HV is an observational, prospective, multi-center, non-randomized study evaluating real-world clinical experience of centers where a single procedural physician schedules eight or more left atrial appendage occlusion (LAAO) device implant procedures in a single calendar day.

Who can take part

Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)

Inclusion criteria

Exclusion criteria

Where it is running

7 locations listed across 6 US states.

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.